Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hexokinase | 0.0114 | 0.0158 | 0.0158 |
Onchocerca volvulus | 0.0114 | 0.0158 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.0023 | 0.0023 |
Toxoplasma gondii | hexokinase | 0.0114 | 0.0158 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Treponema pallidum | hexokinase (hxk) | 0.0114 | 0.0158 | 0.5 |
Plasmodium falciparum | hexokinase | 0.0114 | 0.0158 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2749 | 1 | 1 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.2749 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Trypanosoma brucei | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Onchocerca volvulus | 0.0114 | 0.0158 | 1 | |
Entamoeba histolytica | hexokinase 1 | 0.0114 | 0.0158 | 0.5 |
Trypanosoma brucei | hexokinase | 0.0114 | 0.0158 | 0.5 |
Leishmania major | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Entamoeba histolytica | hexokinase 2 | 0.0114 | 0.0158 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.0114 | 0.0158 | 0.0158 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.2749 | 1 | 1 |
Brugia malayi | hexokinase | 0.0114 | 0.0158 | 0.0158 |
Brugia malayi | Hexokinase family protein | 0.0114 | 0.0158 | 0.0158 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.2749 | 1 | 1 |
Plasmodium vivax | hexokinase, putative | 0.0114 | 0.0158 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0114 | 0.0158 | 0.0158 |
Trypanosoma brucei | hexokinase | 0.0114 | 0.0158 | 0.5 |
Onchocerca volvulus | 0.0114 | 0.0158 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.